Explore 3 Stock Ideas & Industry Insights Download Free Report

News

American Eagle Outfitters Stock (AEO) Falls 3.7% — Aerie Grows While Core Brand Struggles in Competitive Apparel Market

American Eagle Outfitters (NYSE: AEO) shares are declining roughly 3.7% in Monday's session, underperforming the consumer discretionary sector as the company's Q1 fiscal 2026 results reveal a growing performance divide between its two primary brands. The decline comes despite a broader market recovery, suggesting …

Vinay Lochav | 29 June 2026

Ferrari Stock (RACE) Edges Higher — Analyst Conviction Builds Ahead of Q2 Earnings With Deutsche Bank's 30.1% EBIT Margin Forecast

Ferrari (NYSE: RACE) shares are edging modestly higher in Monday's session, buoyed by a wave of bullish analyst activity that is building investor confidence ahead of the company's July 30 Q2 2026 earnings report. Multiple major research firms reaffirmed or upgraded their positions on …

Vinay Lochav | 29 June 2026

Redwire Corp (RDW) Stock Surges 6% — 58% Revenue Growth and Jefferies $24 Street-High Target Drive Space Rally

Redwire Corp (NYSE: RDW) surged over 6% in Monday's session as the combination of improving broad market sentiment — driven by U.S.-Iran ceasefire news — and SpaceX IPO-driven momentum sweeping the space sector amplified the company's already strong fundamental backdrop. Redwire occupies a differentiated …

Vinay Lochav | 29 June 2026

Meta Platforms Stock (META) Rises 3% — Paid Subscriptions Launched, Evercore Reiterates $930 Buy Target

Meta Platforms (NASDAQ: META) shares are rallying nearly 3% in Monday's session, benefiting from a combination of improved broad market sentiment — driven by U.S.-Iran ceasefire news — and a fresh company-specific catalyst: the launch of new paid subscription plans for its Family of …

Vinay Lochav | 29 June 2026

Meta vs. Google vs. Anthropic: The AI Distillation War Heating Up in 2026

A significant competitive development in the AI industry emerged Monday as reports revealed that Meta is restricting internal engineer use of Anthropic's Claude and OpenAI's Codex tools over model distillation concerns. Simultaneously, Google reportedly limited Meta's access to Gemini AI compute capacity. These developments …

Vinay Lochav | 29 June 2026

GE Vernova Stock (GEV) Advances — $150B Backlog and AI Power Demand Drive Infrastructure Rally

GE Vernova (NYSE: GEV) shares are advancing in Monday's session, outperforming both the broader utilities sector and the S&P 500, as investor rotation away from technology hardware and into infrastructure plays gains momentum. The rotation is amplified by the broader market recovery tied to …

Vinay Lochav | 29 June 2026

Eli Lilly Stock (LLY) — Generic Tirzepatide Threat From Sandoz Emerges as GLP-1 Franchise Hits New Heights

Eli Lilly (NYSE: LLY) shares are advancing modestly in Monday's session, consolidating near all-time highs following last week's remarkable 7% single-day surge — the stock's largest one-day gain since February. Today's session brings both positive macro tailwinds — the U.S.-Iran ceasefire is stabilizing the …

Vinay Lochav | 29 June 2026

GLP-1 Obesity Drug Market 2026: Medicare Coverage Expansion, Generic Competition, and Eli Lilly's (LLY) Dominance

The GLP-1 obesity and diabetes drug market is undergoing its most dynamic period of evolution since the class gained widespread recognition, with simultaneous developments in government coverage policy, generic competition timelines, and new molecule advancement all reshaping the competitive landscape. Eli Lilly (NYSE: LLY) …

Vinay Lochav | 29 June 2026

ACM Research Stock (ACMR) Surges 10% — Russell Growth Index Addition and Roth Capital's $125 Buy Target

ACM Research (NASDAQ: ACMR) shares surged nearly 10% in Monday's session, approaching a 52-week high in a session driven by a confluence of powerful catalysts — index reclassification, analyst price target upgrades, and a broader semiconductor sector rebound following U.S.-Iran ceasefire news. The combination …

Vinay Lochav | 29 June 2026

SELLAS Life Sciences (SLS) Stock Surges — Phase 3 REGAL AML Trial Just 2 Events From Final Analysis

SELLAS Life Sciences (NASDAQ: SLS) shares are surging as investors position ahead of what appears to be an imminent readout from the pivotal Phase 3 REGAL trial in acute myeloid leukemia — now just two events away from the 80-event threshold that will trigger …

Vinay Lochav | 29 June 2026
Support

Hi! How can we help you today?

Loading…